Researchers improve blood tests’ ability to detect and monitor cancer
The advance makes it easier to detect circulating tumor DNA in blood samples, which could enable earlier cancer diagnosis and help guide treatment.
New hope for early pancreatic cancer intervention via AI-based risk prediction
MIT CSAIL researchers develop advanced machine-learning models that outperform current methods in detecting pancreatic ductal adenocarcinoma.
Inhalable sensors could enable early lung cancer detection
The diagnostic, which requires only a simple urine test to read the results, could make lung cancer screening more accessible worldwide.
Study: Colon cancer screenings are more effective than previously understood
By reevaluating existing data, researchers find the procedure is even more valuable than consensus had indicated.
MIT’s tiny technologies go to Washington
Cancer nanomedicine was on display at the 2023 White House Demo Day.
Angela Belcher delivers 2023 Dresselhaus Lecture on evolving organisms for new nanomaterials
MIT professor combines nanoscience and viruses to develop solutions in energy, environment, and medicine.
Explained: The sugar coating of life
Researchers are working to advance the field of glycoscience, illuminating the essential role of carbohydrates for human health and disease.
Immune action at a distance
MIT and MGH researchers design a local, gel-based drug-delivery platform that may provoke a system-wide immune response to metastatic tumors.
A new ultrasound patch can measure how full your bladder is
The wearable device, designed to monitor bladder and kidney health, could be adapted for earlier diagnosis of cancers deep within the body.
Teen uses calculus learned through MITx to better understand his cancer treatment
High schooler Dustin Liang estimated his blood cell counts by applying knowledge from an MITx course and talking to doctors.
2023-24 Takeda Fellows: Advancing research at the intersection of AI and health
Thirteen new graduate student fellows will pursue exciting new paths of knowledge and discovery.
Studying cancer in context to stop its growth
MIT spinout Kronos Bio, founded by Associate Professor Angela Koehler, studies the complex signaling networks of cancer cells to find new drug targets.
Future science at the molecular level
Brad Pentelute and his lab compel the anthrax delivery system to deliver antibody and peptide variants into cells to treat cancer.
Study explains why certain immunotherapies don’t always work as predicted
The findings could help doctors identify cancer patients who would benefit the most from drugs called checkpoint blockade inhibitors.
A snapshot of cancer vaccine development
The Koch Institute’s Annual Symposium highlights emerging successes and challenges in the advancement of vaccines to prevent and treat cancer.